EDAP TMS S.A.'s Ablatherm-HIFU to be Showcased at 31st World Congress of Endourology

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LYON, France, Oct. 22, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that its high-intensity focused ultrasound (HIFU) for the treatment of localized prostate cancer, Ablatherm-HIFU, will be featured in multiple presentations addressing minimally invasive prostate cancer therapies and the successful evaluation of EDAP’s device at the 31st World Congress of Endourology (WCE). Top level technical presentations will be made from key opinion leaders in urology, including Dr. Chaussy Christian, Department of Urology, University of Regensburg, Dr. Thuroff Stefan, Department of Urology, Klinikum Munchen Harlaching, and Dr. Sebastian Crouzet, Urologist at Edouard Herriot Hospital in Lyon, France. The WCE is scheduled to take place from October 22-26, 2013, in New Orleans, LA.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC